Research ArticleArticle
Signal Hyperintensities on Brain Magnetic Resonance Imaging in Patients with Primary Sjögren Syndrome and Frequent Episodic Tension-type Headache: Relation to Platelet Serotonin Level and Disease Activity
Helena Šarac, Jasenka Markeljević, Viktorija Erdeljić, Zeljka Josipović-Jelić, Sanja Hajnšek, Tatjana Klapan, Marko Batinica, Ivana Baršić, Jadranka Sertić and Renata Dobrila Dintinjana
The Journal of Rheumatology June 2013, jrheum.121132; DOI: https://doi.org/10.3899/jrheum.121132
Helena Šarac
From the Department of Neurology, University Hospital Zagreb; Croatian Institute for Brain Research, Medical School Zagreb; Medical School, University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Diagnostic Centre Medikol, Zagreb; Department of Laboratory Diagnostic, University Hospital Zagreb, Zagreb; and Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology, Rijeka, Croatia. Supported by the Croatian Ministry of Science, Education and Sport, Projects Sjögren’s Syndrome: Neurohumoral Regulation of Autoimmunity and Atherogenesis, No. 108-1081874-2416 and No. 098 098-1081870-2397. H. Šarac, MD, Department of Neurology, University Hospital Zagreb, Croatian Institute for Brain Research, Medical School Zagreb; J. Markeljevic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; V. Erdeljic, MD, PhD, Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Z. Josipovic-Jelic, MD, PhD, Diagnostic Centre Medikol; S. Hajnšek, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; T. Klapan, MD; M. Batinica, MD, Diagnostic Centre Medikol; I. Barsic, Biochemistry Ing., Department of Laboratory Diagnostic, University Hospital Zagreb; J. Sertic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; R. Dobrila-Dintinjana, MD, PhD, Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology. Address correspondence to Dr. H. Šarac, Department of Neurology, University Hospital Zagreb, Oboj 9b, 10 000 Zagreb, Croatia. E-mail: helenasarac@hi.t-com.hr. Accepted for publication April 4, 2013.
Jasenka Markeljević
From the Department of Neurology, University Hospital Zagreb; Croatian Institute for Brain Research, Medical School Zagreb; Medical School, University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Diagnostic Centre Medikol, Zagreb; Department of Laboratory Diagnostic, University Hospital Zagreb, Zagreb; and Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology, Rijeka, Croatia. Supported by the Croatian Ministry of Science, Education and Sport, Projects Sjögren’s Syndrome: Neurohumoral Regulation of Autoimmunity and Atherogenesis, No. 108-1081874-2416 and No. 098 098-1081870-2397. H. Šarac, MD, Department of Neurology, University Hospital Zagreb, Croatian Institute for Brain Research, Medical School Zagreb; J. Markeljevic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; V. Erdeljic, MD, PhD, Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Z. Josipovic-Jelic, MD, PhD, Diagnostic Centre Medikol; S. Hajnšek, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; T. Klapan, MD; M. Batinica, MD, Diagnostic Centre Medikol; I. Barsic, Biochemistry Ing., Department of Laboratory Diagnostic, University Hospital Zagreb; J. Sertic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; R. Dobrila-Dintinjana, MD, PhD, Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology. Address correspondence to Dr. H. Šarac, Department of Neurology, University Hospital Zagreb, Oboj 9b, 10 000 Zagreb, Croatia. E-mail: helenasarac@hi.t-com.hr. Accepted for publication April 4, 2013.
Viktorija Erdeljić
From the Department of Neurology, University Hospital Zagreb; Croatian Institute for Brain Research, Medical School Zagreb; Medical School, University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Diagnostic Centre Medikol, Zagreb; Department of Laboratory Diagnostic, University Hospital Zagreb, Zagreb; and Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology, Rijeka, Croatia. Supported by the Croatian Ministry of Science, Education and Sport, Projects Sjögren’s Syndrome: Neurohumoral Regulation of Autoimmunity and Atherogenesis, No. 108-1081874-2416 and No. 098 098-1081870-2397. H. Šarac, MD, Department of Neurology, University Hospital Zagreb, Croatian Institute for Brain Research, Medical School Zagreb; J. Markeljevic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; V. Erdeljic, MD, PhD, Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Z. Josipovic-Jelic, MD, PhD, Diagnostic Centre Medikol; S. Hajnšek, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; T. Klapan, MD; M. Batinica, MD, Diagnostic Centre Medikol; I. Barsic, Biochemistry Ing., Department of Laboratory Diagnostic, University Hospital Zagreb; J. Sertic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; R. Dobrila-Dintinjana, MD, PhD, Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology. Address correspondence to Dr. H. Šarac, Department of Neurology, University Hospital Zagreb, Oboj 9b, 10 000 Zagreb, Croatia. E-mail: helenasarac@hi.t-com.hr. Accepted for publication April 4, 2013.
Zeljka Josipović-Jelić
From the Department of Neurology, University Hospital Zagreb; Croatian Institute for Brain Research, Medical School Zagreb; Medical School, University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Diagnostic Centre Medikol, Zagreb; Department of Laboratory Diagnostic, University Hospital Zagreb, Zagreb; and Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology, Rijeka, Croatia. Supported by the Croatian Ministry of Science, Education and Sport, Projects Sjögren’s Syndrome: Neurohumoral Regulation of Autoimmunity and Atherogenesis, No. 108-1081874-2416 and No. 098 098-1081870-2397. H. Šarac, MD, Department of Neurology, University Hospital Zagreb, Croatian Institute for Brain Research, Medical School Zagreb; J. Markeljevic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; V. Erdeljic, MD, PhD, Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Z. Josipovic-Jelic, MD, PhD, Diagnostic Centre Medikol; S. Hajnšek, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; T. Klapan, MD; M. Batinica, MD, Diagnostic Centre Medikol; I. Barsic, Biochemistry Ing., Department of Laboratory Diagnostic, University Hospital Zagreb; J. Sertic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; R. Dobrila-Dintinjana, MD, PhD, Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology. Address correspondence to Dr. H. Šarac, Department of Neurology, University Hospital Zagreb, Oboj 9b, 10 000 Zagreb, Croatia. E-mail: helenasarac@hi.t-com.hr. Accepted for publication April 4, 2013.
Sanja Hajnšek
From the Department of Neurology, University Hospital Zagreb; Croatian Institute for Brain Research, Medical School Zagreb; Medical School, University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Diagnostic Centre Medikol, Zagreb; Department of Laboratory Diagnostic, University Hospital Zagreb, Zagreb; and Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology, Rijeka, Croatia. Supported by the Croatian Ministry of Science, Education and Sport, Projects Sjögren’s Syndrome: Neurohumoral Regulation of Autoimmunity and Atherogenesis, No. 108-1081874-2416 and No. 098 098-1081870-2397. H. Šarac, MD, Department of Neurology, University Hospital Zagreb, Croatian Institute for Brain Research, Medical School Zagreb; J. Markeljevic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; V. Erdeljic, MD, PhD, Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Z. Josipovic-Jelic, MD, PhD, Diagnostic Centre Medikol; S. Hajnšek, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; T. Klapan, MD; M. Batinica, MD, Diagnostic Centre Medikol; I. Barsic, Biochemistry Ing., Department of Laboratory Diagnostic, University Hospital Zagreb; J. Sertic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; R. Dobrila-Dintinjana, MD, PhD, Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology. Address correspondence to Dr. H. Šarac, Department of Neurology, University Hospital Zagreb, Oboj 9b, 10 000 Zagreb, Croatia. E-mail: helenasarac@hi.t-com.hr. Accepted for publication April 4, 2013.
Tatjana Klapan
From the Department of Neurology, University Hospital Zagreb; Croatian Institute for Brain Research, Medical School Zagreb; Medical School, University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Diagnostic Centre Medikol, Zagreb; Department of Laboratory Diagnostic, University Hospital Zagreb, Zagreb; and Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology, Rijeka, Croatia. Supported by the Croatian Ministry of Science, Education and Sport, Projects Sjögren’s Syndrome: Neurohumoral Regulation of Autoimmunity and Atherogenesis, No. 108-1081874-2416 and No. 098 098-1081870-2397. H. Šarac, MD, Department of Neurology, University Hospital Zagreb, Croatian Institute for Brain Research, Medical School Zagreb; J. Markeljevic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; V. Erdeljic, MD, PhD, Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Z. Josipovic-Jelic, MD, PhD, Diagnostic Centre Medikol; S. Hajnšek, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; T. Klapan, MD; M. Batinica, MD, Diagnostic Centre Medikol; I. Barsic, Biochemistry Ing., Department of Laboratory Diagnostic, University Hospital Zagreb; J. Sertic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; R. Dobrila-Dintinjana, MD, PhD, Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology. Address correspondence to Dr. H. Šarac, Department of Neurology, University Hospital Zagreb, Oboj 9b, 10 000 Zagreb, Croatia. E-mail: helenasarac@hi.t-com.hr. Accepted for publication April 4, 2013.
Marko Batinica
From the Department of Neurology, University Hospital Zagreb; Croatian Institute for Brain Research, Medical School Zagreb; Medical School, University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Diagnostic Centre Medikol, Zagreb; Department of Laboratory Diagnostic, University Hospital Zagreb, Zagreb; and Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology, Rijeka, Croatia. Supported by the Croatian Ministry of Science, Education and Sport, Projects Sjögren’s Syndrome: Neurohumoral Regulation of Autoimmunity and Atherogenesis, No. 108-1081874-2416 and No. 098 098-1081870-2397. H. Šarac, MD, Department of Neurology, University Hospital Zagreb, Croatian Institute for Brain Research, Medical School Zagreb; J. Markeljevic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; V. Erdeljic, MD, PhD, Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Z. Josipovic-Jelic, MD, PhD, Diagnostic Centre Medikol; S. Hajnšek, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; T. Klapan, MD; M. Batinica, MD, Diagnostic Centre Medikol; I. Barsic, Biochemistry Ing., Department of Laboratory Diagnostic, University Hospital Zagreb; J. Sertic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; R. Dobrila-Dintinjana, MD, PhD, Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology. Address correspondence to Dr. H. Šarac, Department of Neurology, University Hospital Zagreb, Oboj 9b, 10 000 Zagreb, Croatia. E-mail: helenasarac@hi.t-com.hr. Accepted for publication April 4, 2013.
Ivana Baršić
From the Department of Neurology, University Hospital Zagreb; Croatian Institute for Brain Research, Medical School Zagreb; Medical School, University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Diagnostic Centre Medikol, Zagreb; Department of Laboratory Diagnostic, University Hospital Zagreb, Zagreb; and Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology, Rijeka, Croatia. Supported by the Croatian Ministry of Science, Education and Sport, Projects Sjögren’s Syndrome: Neurohumoral Regulation of Autoimmunity and Atherogenesis, No. 108-1081874-2416 and No. 098 098-1081870-2397. H. Šarac, MD, Department of Neurology, University Hospital Zagreb, Croatian Institute for Brain Research, Medical School Zagreb; J. Markeljevic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; V. Erdeljic, MD, PhD, Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Z. Josipovic-Jelic, MD, PhD, Diagnostic Centre Medikol; S. Hajnšek, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; T. Klapan, MD; M. Batinica, MD, Diagnostic Centre Medikol; I. Barsic, Biochemistry Ing., Department of Laboratory Diagnostic, University Hospital Zagreb; J. Sertic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; R. Dobrila-Dintinjana, MD, PhD, Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology. Address correspondence to Dr. H. Šarac, Department of Neurology, University Hospital Zagreb, Oboj 9b, 10 000 Zagreb, Croatia. E-mail: helenasarac@hi.t-com.hr. Accepted for publication April 4, 2013.
Jadranka Sertić
From the Department of Neurology, University Hospital Zagreb; Croatian Institute for Brain Research, Medical School Zagreb; Medical School, University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Diagnostic Centre Medikol, Zagreb; Department of Laboratory Diagnostic, University Hospital Zagreb, Zagreb; and Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology, Rijeka, Croatia. Supported by the Croatian Ministry of Science, Education and Sport, Projects Sjögren’s Syndrome: Neurohumoral Regulation of Autoimmunity and Atherogenesis, No. 108-1081874-2416 and No. 098 098-1081870-2397. H. Šarac, MD, Department of Neurology, University Hospital Zagreb, Croatian Institute for Brain Research, Medical School Zagreb; J. Markeljevic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; V. Erdeljic, MD, PhD, Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Z. Josipovic-Jelic, MD, PhD, Diagnostic Centre Medikol; S. Hajnšek, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; T. Klapan, MD; M. Batinica, MD, Diagnostic Centre Medikol; I. Barsic, Biochemistry Ing., Department of Laboratory Diagnostic, University Hospital Zagreb; J. Sertic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; R. Dobrila-Dintinjana, MD, PhD, Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology. Address correspondence to Dr. H. Šarac, Department of Neurology, University Hospital Zagreb, Oboj 9b, 10 000 Zagreb, Croatia. E-mail: helenasarac@hi.t-com.hr. Accepted for publication April 4, 2013.
Renata Dobrila Dintinjana
From the Department of Neurology, University Hospital Zagreb; Croatian Institute for Brain Research, Medical School Zagreb; Medical School, University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Diagnostic Centre Medikol, Zagreb; Department of Laboratory Diagnostic, University Hospital Zagreb, Zagreb; and Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology, Rijeka, Croatia. Supported by the Croatian Ministry of Science, Education and Sport, Projects Sjögren’s Syndrome: Neurohumoral Regulation of Autoimmunity and Atherogenesis, No. 108-1081874-2416 and No. 098 098-1081870-2397. H. Šarac, MD, Department of Neurology, University Hospital Zagreb, Croatian Institute for Brain Research, Medical School Zagreb; J. Markeljevic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; V. Erdeljic, MD, PhD, Division of Clinical Pharmacology, Department of Medicine, University Hospital Zagreb; Z. Josipovic-Jelic, MD, PhD, Diagnostic Centre Medikol; S. Hajnšek, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; T. Klapan, MD; M. Batinica, MD, Diagnostic Centre Medikol; I. Barsic, Biochemistry Ing., Department of Laboratory Diagnostic, University Hospital Zagreb; J. Sertic, MD, PhD, Medical School University of Zagreb, Department of Internal Medicine, University Hospital Sisters of Mercy; R. Dobrila-Dintinjana, MD, PhD, Medical School University of Rijeka, University Hospital Rijeka, Department of Oncology. Address correspondence to Dr. H. Šarac, Department of Neurology, University Hospital Zagreb, Oboj 9b, 10 000 Zagreb, Croatia. E-mail: helenasarac@hi.t-com.hr. Accepted for publication April 4, 2013.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Signal Hyperintensities on Brain Magnetic Resonance Imaging in Patients with Primary Sjögren Syndrome and Frequent Episodic Tension-type Headache: Relation to Platelet Serotonin Level and Disease Activity
Helena Šarac, Jasenka Markeljević, Viktorija Erdeljić, Zeljka Josipović-Jelić, Sanja Hajnšek, Tatjana Klapan, Marko Batinica, Ivana Baršić, Jadranka Sertić, Renata Dobrila Dintinjana
The Journal of Rheumatology Jun 2013, jrheum.121132; DOI: 10.3899/jrheum.121132
Signal Hyperintensities on Brain Magnetic Resonance Imaging in Patients with Primary Sjögren Syndrome and Frequent Episodic Tension-type Headache: Relation to Platelet Serotonin Level and Disease Activity
Helena Šarac, Jasenka Markeljević, Viktorija Erdeljić, Zeljka Josipović-Jelić, Sanja Hajnšek, Tatjana Klapan, Marko Batinica, Ivana Baršić, Jadranka Sertić, Renata Dobrila Dintinjana
The Journal of Rheumatology Jun 2013, jrheum.121132; DOI: 10.3899/jrheum.121132